Floatz logo

Therapeutic Asset Ratings

1,045 results matching 1 filter

133,990 assets · 8,802 sponsors · 3,128 indications
Methodology v0.2
AssetSponsorPhaseRating
Trastuzumab Emtansine
Breast Inflammatory Carcinoma
Hoffmann-La RocheP3BB (67)
Brentuximab Vedotin
Ann Arbor Stage I Primary Mediastinal (Thymic) Large B-Cell Lymphoma
M.D. Anderson Cancer CenterP2BB (67)
rc48-adc
Advanced Gastroesophageal Junction Adenocarcinoma
BeOne MedicinesP2BB (67)
Tisotumab Vedotin
Carcinoma, Squamous Cell of Head and Neck
Seagen, a wholly owned subsidiary of PfizerP2BB (67)
rc48-adc
Small Cell Lung Cancer
BeOne MedicinesP4BB (66)
Trastuzumab Deruxtecan
Brain Metastases
Baptist Health South FloridaP4BB (66)
Trastuzumab Emtansine
HER2-positive Breast Cancer
SWOG Cancer Research NetworkP4BB (66)
Brentuximab Vedotin
Adult Mixed Cellularity Hodgkin Lymphoma
National Cancer Institute (NCI)P3BB (66)
Brentuximab Vedotin
Adult Nodular Sclerosis Hodgkin Lymphoma
National Cancer Institute (NCI)P3BB (66)
Brentuximab Vedotin
Classical Hodgkin Lymphoma
National Cancer Institute (NCI)P3BB (66)
Brentuximab Vedotin
Classic Hodgkin Lymphoma
National Cancer Institute (NCI)P3BB (66)
Brentuximab Vedotin
Lymphocyte-Rich Classic Hodgkin Lymphoma
National Cancer Institute (NCI)P3BB (66)
Inotuzumab Ozogamicin
B Lymphoblastic Lymphoma
Alliance for Clinical Trials in OncologyP3BB (66)
rc48-adc
Gastric Neoplasms
Seagen, a wholly owned subsidiary of PfizerP3BB (66)
Trastuzumab Emtansine
Breast Cancer
SWOG Cancer Research NetworkP3BB (66)
Trastuzumab Emtansine
Stage IV Breast Cancer
SWOG Cancer Research NetworkP3BB (66)
ENFORTUMAB VEDOTIN (fully human monoclonal antibody conjugated to a cytotoxic agent monomethyl auristatin E (MMAE) targeting nectin-4)
Metastatic Urothelial Carcinoma of the Renal Pelvis and Ureter
National Cancer Institute (NCI)P2BB (66)
ENFORTUMAB VEDOTIN (fully human monoclonal antibody conjugated to a cytotoxic agent monomethyl auristatin E (MMAE) targeting nectin-4)
Stage IIIB Bladder Cancer AJCC v8
Fred Hutchinson Cancer CenterP2BB (66)
Gemtuzumab Ozogamicin
Recurrent Adult Acute Myeloid Leukemia
Medical College of WisconsinP2BB (66)
Trastuzumab Deruxtecan
Colon Cancer Metastatic
M.D. Anderson Cancer CenterP2BB (66)
ENFORTUMAB VEDOTIN (fully human monoclonal antibody conjugated to a cytotoxic agent monomethyl auristatin E (MMAE) targeting nectin-4)
Advanced or Metastatic Solid Malignancies
National Cancer Institute (NCI)P2/3BB (66)
Datopotamab Deruxtecan
Stomatitis
AstraZenecaP4BB (65)
rc48-adc
Neoadjuvant Therapy
First Affiliated Hospital of Guangxi Medical UniversityP4BB (65)
Brentuximab Vedotin
Lymphoma, Non-Hodgkin
New York Medical CollegeP3BB (65)
Polatuzumab Vedotin
Non-Hodgkin Lymphoma
GenmabP3BB (65)
Showing 26 to 50 of 1,045 assets
PreviousPage 2 of 42Next